Each reference below was re-fetched from its PubMed record, and the quoted sentence was
confirmed to appear in that abstract and to support the claim it sits under. Follow any of
them to read the source.
Mechanism/effect boundary: in a research program spanning 39 high-performance athletes, an oral ketone ester induced ketosis without the confound of caloric or carbohydrate restriction; the same study reported that this metabolic state altered fuel competition for oxidative respiration during exercise.
Thus, we studied the biochemical advantages of ketosis in humans using a ketone ester-based form of nutrition without the unwanted milieu of endogenous ketone body production by caloric or carbohydrate restriction.
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. Cell metabolism · 2016 · PMID 27475046
Evidence scope. Human, oral ketone ESTER specifically (not salt or free acid), high-performance athletes (n=39 across 5 sub-studies) — not evidence for ketone salts or exogenous BHB acid.
Salt-form safety boundary: ketone salts can cause gastrointestinal distress from excessive mineral consumption.
However, strict adaptation to the KD was often associated with poor patient compliance, while the ingestion of KS caused gastrointestinal distresses due to excessive consumption of minerals.
On the nutritional and therapeutic effects of ketone body D-β-hydroxybutyrate. Applied microbiology and biotechnology · 2021 · PMID 34415393
Evidence scope. Narrative review synthesis (not a single trial); statement is specific to the ketone SALT (KS) formulation, not ester (KE) or diet-induced ketosis (KD).
Dose/formulation boundary: a pilot used drinks containing 5 g R-beta-hydroxybutyric acid plus 5 g R-1,3-butanediol three times daily; this is not a pure BHB salt or ester.
Individuals living with T2D (N = 40) were randomized to 90 days of thrice daily BHB-containing supplement ingestion (ketone; 5 g of R-β-hydroxybutyric acid with 5 g of R-1,3-butanediol; i.e., 3 × 10g of daily ketone servings) or a taste-matched calorie-free placebo.
Examining the Feasibility of Prolonged Beta-Hydroxybutyrate-Containing Supplement Drink Consumption in Adults with Type 2 Diabetes: A Randomized Controlled Pilot Trial. Journal of the American Nutrition Association · 2025 · PMID 40525864
Evidence scope. Human pilot RCT, adults with type 2 diabetes specifically (disease population, not healthy adults), n=40; mixed ketone-diol drink, not a pure BHB salt or ester.
Primary safety: the BHB-containing drink had a 40% dropout rate, mostly from GI symptoms and unpleasant taste.
Most feasibility criteria were met, except there was a relatively high drop-out rate in the ketone (8 participants, 40%) compared to the placebo (2 participants, 10%) group, mostly related to GI symptoms and unpleasant supplement taste.
Examining the Feasibility of Prolonged Beta-Hydroxybutyrate-Containing Supplement Drink Consumption in Adults with Type 2 Diabetes: A Randomized Controlled Pilot Trial. Journal of the American Nutrition Association · 2025 · PMID 40525864
Evidence scope. Same T2D pilot RCT (n=40, 20/arm), oral mixed ketone-diol drink, 90 days — dropout data specific to this formulation/population, not generalizable to other BHB products or healthy users.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the
same as saying they are false — it marks where the evidence is missing.
Exact dose/formulation: 5-15 g BHB salts or ester per dose. No checked abstract matched both the displayed 5-15 g amount and the exact salt-or-ester formulation.